nodes	percent_of_prediction	percent_of_DWPC	metapath
Masoprocol—IGF1R—type 2 diabetes mellitus	0.795	1	CbGaD
Masoprocol—CYP2J2—artery—type 2 diabetes mellitus	0.00536	0.148	CbGeAlD
Masoprocol—LTB4R—adipose tissue—type 2 diabetes mellitus	0.00293	0.0808	CbGeAlD
Masoprocol—IGF1R—cardiovascular system—type 2 diabetes mellitus	0.00275	0.0757	CbGeAlD
Masoprocol—IGF1R—kidney—type 2 diabetes mellitus	0.00269	0.074	CbGeAlD
Masoprocol—IGF1R—pancreas—type 2 diabetes mellitus	0.00267	0.0735	CbGeAlD
Masoprocol—IGF1R—adipose tissue—type 2 diabetes mellitus	0.00242	0.0667	CbGeAlD
Masoprocol—CYP2J2—nephron tubule—type 2 diabetes mellitus	0.00207	0.0571	CbGeAlD
Masoprocol—LTB4R—liver—type 2 diabetes mellitus	0.00206	0.0567	CbGeAlD
Masoprocol—ALOX5—islet of Langerhans—type 2 diabetes mellitus	0.00203	0.0559	CbGeAlD
Masoprocol—Isoprenaline—PIK3R1—type 2 diabetes mellitus	0.002	0.346	CrCbGaD
Masoprocol—CYP2J2—cardiovascular system—type 2 diabetes mellitus	0.00186	0.0513	CbGeAlD
Masoprocol—IGF1R—liver—type 2 diabetes mellitus	0.0017	0.0468	CbGeAlD
Masoprocol—Fenoterol—ADRB3—type 2 diabetes mellitus	0.00148	0.256	CrCbGaD
Masoprocol—ALOX5—cardiovascular system—type 2 diabetes mellitus	0.00147	0.0404	CbGeAlD
Masoprocol—ALOX5—pancreas—type 2 diabetes mellitus	0.00143	0.0393	CbGeAlD
Masoprocol—Arbutamine—ADRB3—type 2 diabetes mellitus	0.00139	0.239	CrCbGaD
Masoprocol—ALOX5—adipose tissue—type 2 diabetes mellitus	0.00129	0.0356	CbGeAlD
Masoprocol—CYP2J2—liver—type 2 diabetes mellitus	0.00115	0.0317	CbGeAlD
Masoprocol—ALOX5—liver—type 2 diabetes mellitus	0.000907	0.025	CbGeAlD
Masoprocol—CYP19A1—adipose tissue—type 2 diabetes mellitus	0.000894	0.0246	CbGeAlD
Masoprocol—Isoprenaline—ADRB3—type 2 diabetes mellitus	0.000724	0.125	CrCbGaD
Masoprocol—CYP19A1—liver—type 2 diabetes mellitus	0.000627	0.0173	CbGeAlD
Masoprocol—Dopamine—CYP1A2—type 2 diabetes mellitus	0.000196	0.0338	CrCbGaD
Masoprocol—ALOX5—Metabolism—GCK—type 2 diabetes mellitus	3.96e-05	0.000243	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—AVP—type 2 diabetes mellitus	3.94e-05	0.000242	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PTPN1—type 2 diabetes mellitus	3.94e-05	0.000242	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—GCG—type 2 diabetes mellitus	3.94e-05	0.000242	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.94e-05	0.000242	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP11A1—type 2 diabetes mellitus	3.94e-05	0.000242	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.92e-05	0.000241	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CTGF—type 2 diabetes mellitus	3.91e-05	0.00024	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.9e-05	0.00024	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—HMGCR—type 2 diabetes mellitus	3.88e-05	0.000238	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	3.87e-05	0.000238	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—SLC9A1—type 2 diabetes mellitus	3.87e-05	0.000237	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	3.86e-05	0.000237	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	3.86e-05	0.000237	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GCGR—type 2 diabetes mellitus	3.86e-05	0.000237	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.82e-05	0.000235	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CETP—type 2 diabetes mellitus	3.82e-05	0.000235	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—APOB—type 2 diabetes mellitus	3.8e-05	0.000234	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ADRA2A—type 2 diabetes mellitus	3.79e-05	0.000233	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.79e-05	0.000233	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.74e-05	0.00023	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	3.72e-05	0.000228	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—type 2 diabetes mellitus	3.66e-05	0.000225	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP2E1—type 2 diabetes mellitus	3.65e-05	0.000224	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYTB—type 2 diabetes mellitus	3.65e-05	0.000224	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—OXCT1—type 2 diabetes mellitus	3.65e-05	0.000224	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—LPL—type 2 diabetes mellitus	3.63e-05	0.000223	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—SLC2A1—type 2 diabetes mellitus	3.6e-05	0.000221	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP1A2—type 2 diabetes mellitus	3.6e-05	0.000221	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.56e-05	0.000219	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.56e-05	0.000218	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—SREBF1—type 2 diabetes mellitus	3.55e-05	0.000218	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PSMD6—type 2 diabetes mellitus	3.55e-05	0.000218	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SRD5A1—type 2 diabetes mellitus	3.55e-05	0.000218	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—SNAP25—type 2 diabetes mellitus	3.55e-05	0.000218	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP3A4—type 2 diabetes mellitus	3.51e-05	0.000216	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.5e-05	0.000215	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CTGF—type 2 diabetes mellitus	3.49e-05	0.000214	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—HMGCR—type 2 diabetes mellitus	3.46e-05	0.000212	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GCG—type 2 diabetes mellitus	3.46e-05	0.000212	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—SLC2A4—type 2 diabetes mellitus	3.46e-05	0.000212	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	3.42e-05	0.00021	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.41e-05	0.000209	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.41e-05	0.000209	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—GNB3—type 2 diabetes mellitus	3.39e-05	0.000208	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ACACA—type 2 diabetes mellitus	3.39e-05	0.000208	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—HSD17B3—type 2 diabetes mellitus	3.39e-05	0.000208	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—STAR—type 2 diabetes mellitus	3.39e-05	0.000208	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ADRA2A—type 2 diabetes mellitus	3.38e-05	0.000208	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—AVP—type 2 diabetes mellitus	3.35e-05	0.000206	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.35e-05	0.000206	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.35e-05	0.000206	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.33e-05	0.000205	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.32e-05	0.000204	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—EGFR—type 2 diabetes mellitus	3.29e-05	0.000202	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—C3—type 2 diabetes mellitus	3.27e-05	0.000201	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP2E1—type 2 diabetes mellitus	3.25e-05	0.0002	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ABCC8—type 2 diabetes mellitus	3.25e-05	0.0002	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CBS—type 2 diabetes mellitus	3.25e-05	0.0002	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—APOB—type 2 diabetes mellitus	3.24e-05	0.000199	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP1A2—type 2 diabetes mellitus	3.21e-05	0.000197	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—SLC2A1—type 2 diabetes mellitus	3.21e-05	0.000197	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.18e-05	0.000196	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP3A4—type 2 diabetes mellitus	3.13e-05	0.000192	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—COX2—type 2 diabetes mellitus	3.13e-05	0.000192	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SLC5A2—type 2 diabetes mellitus	3.13e-05	0.000192	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.12e-05	0.000192	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.12e-05	0.000191	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.11e-05	0.000191	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—AGT—type 2 diabetes mellitus	3.11e-05	0.000191	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—LPL—type 2 diabetes mellitus	3.09e-05	0.00019	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GCG—type 2 diabetes mellitus	3.08e-05	0.000189	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—SLC2A4—type 2 diabetes mellitus	3.08e-05	0.000189	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NCOA6—type 2 diabetes mellitus	3.07e-05	0.000189	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	3.07e-05	0.000189	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.06e-05	0.000188	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—LEP—type 2 diabetes mellitus	3.05e-05	0.000187	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—APOE—type 2 diabetes mellitus	3.05e-05	0.000187	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.02e-05	0.000186	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—UCP3—type 2 diabetes mellitus	3.02e-05	0.000186	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—HSD11B1—type 2 diabetes mellitus	3.02e-05	0.000186	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—UCP2—type 2 diabetes mellitus	3.02e-05	0.000186	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.01e-05	0.000185	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.98e-05	0.000183	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GNB3—type 2 diabetes mellitus	2.98e-05	0.000183	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—HMOX1—type 2 diabetes mellitus	2.96e-05	0.000182	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	2.93e-05	0.00018	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CAT—type 2 diabetes mellitus	2.93e-05	0.00018	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.9e-05	0.000178	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.87e-05	0.000176	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.85e-05	0.000175	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PCK1—type 2 diabetes mellitus	2.84e-05	0.000174	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—APOB—type 2 diabetes mellitus	2.84e-05	0.000174	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	2.8e-05	0.000172	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—C3—type 2 diabetes mellitus	2.78e-05	0.000171	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GSTM1—type 2 diabetes mellitus	2.76e-05	0.00017	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	2.73e-05	0.000168	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.72e-05	0.000167	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—LPL—type 2 diabetes mellitus	2.71e-05	0.000167	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—HK1—type 2 diabetes mellitus	2.66e-05	0.000163	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	2.66e-05	0.000163	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.65e-05	0.000163	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GNB3—type 2 diabetes mellitus	2.65e-05	0.000163	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ADCY5—type 2 diabetes mellitus	2.65e-05	0.000163	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.65e-05	0.000163	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.65e-05	0.000163	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GPX1—type 2 diabetes mellitus	2.65e-05	0.000162	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—AGT—type 2 diabetes mellitus	2.64e-05	0.000162	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—HMOX1—type 2 diabetes mellitus	2.64e-05	0.000162	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CAT—type 2 diabetes mellitus	2.61e-05	0.00016	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—INS—type 2 diabetes mellitus	2.6e-05	0.00016	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.6e-05	0.00016	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—LEP—type 2 diabetes mellitus	2.59e-05	0.000159	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—APOE—type 2 diabetes mellitus	2.59e-05	0.000159	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CD36—type 2 diabetes mellitus	2.58e-05	0.000158	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—LPA—type 2 diabetes mellitus	2.57e-05	0.000158	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—HSD3B2—type 2 diabetes mellitus	2.57e-05	0.000158	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—KCNJ11—type 2 diabetes mellitus	2.57e-05	0.000158	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GCKR—type 2 diabetes mellitus	2.57e-05	0.000158	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.56e-05	0.000157	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.56e-05	0.000157	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.54e-05	0.000156	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—APOB—type 2 diabetes mellitus	2.53e-05	0.000155	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.52e-05	0.000155	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.51e-05	0.000154	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.5e-05	0.000154	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	2.47e-05	0.000152	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GSTM1—type 2 diabetes mellitus	2.46e-05	0.000151	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ALDOB—type 2 diabetes mellitus	2.46e-05	0.000151	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.44e-05	0.00015	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—MTHFR—type 2 diabetes mellitus	2.44e-05	0.00015	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—LPL—type 2 diabetes mellitus	2.42e-05	0.000148	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PPARA—type 2 diabetes mellitus	2.4e-05	0.000147	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2.39e-05	0.000147	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.39e-05	0.000147	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ADCY5—type 2 diabetes mellitus	2.37e-05	0.000145	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GPX1—type 2 diabetes mellitus	2.36e-05	0.000145	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.34e-05	0.000144	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—AKT1—type 2 diabetes mellitus	2.33e-05	0.000143	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—AGT—type 2 diabetes mellitus	2.32e-05	0.000142	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	2.32e-05	0.000142	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.31e-05	0.000142	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CD36—type 2 diabetes mellitus	2.3e-05	0.000141	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GLP1R—type 2 diabetes mellitus	2.29e-05	0.000141	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.28e-05	0.00014	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.28e-05	0.00014	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CALM1—type 2 diabetes mellitus	2.28e-05	0.00014	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—APOE—type 2 diabetes mellitus	2.27e-05	0.00014	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PPP2CA—type 2 diabetes mellitus	2.27e-05	0.000139	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—APOA1—type 2 diabetes mellitus	2.25e-05	0.000138	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—INS—type 2 diabetes mellitus	2.21e-05	0.000136	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.18e-05	0.000134	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—MTHFR—type 2 diabetes mellitus	2.18e-05	0.000134	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—RELA—type 2 diabetes mellitus	2.15e-05	0.000132	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.14e-05	0.000131	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.14e-05	0.000131	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SLC2A2—type 2 diabetes mellitus	2.14e-05	0.000131	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PPARA—type 2 diabetes mellitus	2.13e-05	0.000131	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CPT1A—type 2 diabetes mellitus	2.09e-05	0.000129	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—MTR—type 2 diabetes mellitus	2.09e-05	0.000129	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—AGT—type 2 diabetes mellitus	2.07e-05	0.000127	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NAMPT—type 2 diabetes mellitus	2.05e-05	0.000126	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	2.04e-05	0.000125	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—LIPC—type 2 diabetes mellitus	2.04e-05	0.000125	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GCK—type 2 diabetes mellitus	2.04e-05	0.000125	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—HBA1—type 2 diabetes mellitus	2.04e-05	0.000125	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CALM1—type 2 diabetes mellitus	2.03e-05	0.000125	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.03e-05	0.000125	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP11A1—type 2 diabetes mellitus	2.03e-05	0.000125	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—APOE—type 2 diabetes mellitus	2.03e-05	0.000124	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—APOA1—type 2 diabetes mellitus	2e-05	0.000123	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.99e-05	0.000122	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PPARG—type 2 diabetes mellitus	1.98e-05	0.000122	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CETP—type 2 diabetes mellitus	1.97e-05	0.000121	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.95e-05	0.00012	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—INS—type 2 diabetes mellitus	1.94e-05	0.000119	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.94e-05	0.000119	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.94e-05	0.000119	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.94e-05	0.000119	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.92e-05	0.000118	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.84e-05	0.000113	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.83e-05	0.000112	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SREBF1—type 2 diabetes mellitus	1.83e-05	0.000112	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SNAP25—type 2 diabetes mellitus	1.83e-05	0.000112	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PSMD6—type 2 diabetes mellitus	1.83e-05	0.000112	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—RELA—type 2 diabetes mellitus	1.83e-05	0.000112	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.81e-05	0.000111	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CTGF—type 2 diabetes mellitus	1.8e-05	0.00011	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—HMGCR—type 2 diabetes mellitus	1.78e-05	0.000109	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ALB—type 2 diabetes mellitus	1.78e-05	0.000109	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.78e-05	0.000109	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PPARG—type 2 diabetes mellitus	1.76e-05	0.000108	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.76e-05	0.000108	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.74e-05	0.000107	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—INS—type 2 diabetes mellitus	1.73e-05	0.000106	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.7e-05	0.000105	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—NOS3—type 2 diabetes mellitus	1.7e-05	0.000105	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—SRC—type 2 diabetes mellitus	1.69e-05	0.000104	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.67e-05	0.000103	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.65e-05	0.000102	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.65e-05	0.000102	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.65e-05	0.000101	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.64e-05	0.000101	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.61e-05	9.91e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.61e-05	9.86e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.59e-05	9.75e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GCG—type 2 diabetes mellitus	1.59e-05	9.75e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ALB—type 2 diabetes mellitus	1.59e-05	9.75e-05	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PTGS2—type 2 diabetes mellitus	1.56e-05	9.57e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.56e-05	9.56e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.54e-05	9.46e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PIK3R1—type 2 diabetes mellitus	1.52e-05	9.32e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—NOS3—type 2 diabetes mellitus	1.52e-05	9.32e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.51e-05	9.27e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.48e-05	9.09e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—SRC—type 2 diabetes mellitus	1.43e-05	8.81e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.4e-05	8.58e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PTGS2—type 2 diabetes mellitus	1.39e-05	8.53e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.37e-05	8.4e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GNB3—type 2 diabetes mellitus	1.37e-05	8.4e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—HMOX1—type 2 diabetes mellitus	1.36e-05	8.36e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CAT—type 2 diabetes mellitus	1.34e-05	8.25e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—APOB—type 2 diabetes mellitus	1.3e-05	8.01e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.28e-05	7.88e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTM1—type 2 diabetes mellitus	1.27e-05	7.79e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.26e-05	7.73e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—LPL—type 2 diabetes mellitus	1.25e-05	7.65e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ADCY5—type 2 diabetes mellitus	1.22e-05	7.49e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GPX1—type 2 diabetes mellitus	1.21e-05	7.46e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CD36—type 2 diabetes mellitus	1.18e-05	7.27e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.17e-05	7.18e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IL6—type 2 diabetes mellitus	1.14e-05	6.98e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—MTHFR—type 2 diabetes mellitus	1.12e-05	6.89e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PPARA—type 2 diabetes mellitus	1.1e-05	6.76e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—AGT—type 2 diabetes mellitus	1.07e-05	6.54e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.05e-05	6.44e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CALM1—type 2 diabetes mellitus	1.05e-05	6.43e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—APOE—type 2 diabetes mellitus	1.04e-05	6.41e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—APOA1—type 2 diabetes mellitus	1.03e-05	6.34e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IL6—type 2 diabetes mellitus	9.67e-06	5.94e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PPARG—type 2 diabetes mellitus	9.09e-06	5.58e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.92e-06	5.48e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—INS—type 2 diabetes mellitus	8.92e-06	5.48e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ALB—type 2 diabetes mellitus	8.17e-06	5.02e-05	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—AKT1—type 2 diabetes mellitus	7.83e-06	4.81e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NOS3—type 2 diabetes mellitus	7.82e-06	4.8e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PIK3R1—type 2 diabetes mellitus	7.82e-06	4.8e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PTGS2—type 2 diabetes mellitus	7.15e-06	4.39e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—AKT1—type 2 diabetes mellitus	6.98e-06	4.29e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—AKT1—type 2 diabetes mellitus	3.59e-06	2.21e-05	CbGpPWpGaD
